← Eichor
Study identifier: NCT05818605 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Condition: Hypertrophic Cardiomyopathy  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants70
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Cynthia Partida-Higuera, CCRP  ·  415-514-1125  ·  Cynthia.Partida-Higuera@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California - San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05818605